UPDATE 1-Study preserves hopes for Roche's Tecentriq in lung cancer

ZURICH, June 25 (Reuters) - Swiss drugmaker Roche's hopes of having the first immunotherapy cocktail to be approved as an initial treatment for an aggressive form of lung cancer remained intact on Monday after a trial showed positive survival data.

from Reuters: Company News https://ift.tt/2InWVEf
via IFTTT